This detailed Report provides an Earnings and Dividends history for Nventa Biopharmaceuticals Corporation. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.
Nventa Biopharmaceuticals Corporation. The Group's principal activity is to discover, develop and commercialize innovative stress protein-based immunotherapeutics, also known as therapeutic vaccines, which are used for the treatment of infectious diseases and cancers. The Group uses a specific and unique class of proteins, called stress proteins, to regulate immune responses for therapeutic applications. The Group has market for its products in the United States, Canada and other Countries.
Not the Report you are looking for?Click here for more browsing options.
* If a currency is not selected, the report will be delivered in the local currency of the company ** Full access limits users to 500 reports per month
Web site and selected data copyright 2008 The Winthrop Corporation. All rights reserved. Selected data copyright 2008, "Worldscope/Disclosure, L.L.C., a Primark affiliate." All rights reserved.
